by Richard Daverman, PhD
December 30, 2013 -- Chugai Pharma will take its China drug marketing/distribution in-house with a $30 million investment in Taizhou’s China Medical City. At present, Chugai outsources its China sales activities to local drugmakers and wholesalers. The company said the initiative comes as a result of China’s growing pharma market and will provide greater flexibility. A Japanese drugmaker, Chugai is majority-owned (almost 60%) by Hoffman-La Roche. More details....
Stock Symbol: (JP: 4519)
Help employers find you! Check out all the jobs and post your resume.
